ROCK-II inhibitor(1273579-40-0)
- Name: ROCK-II inhibitor
- Synonyms:2H-1-Benzopyran-3-carboxamide, N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-3,4-dihydro-6-methoxy-, (3S)-;
- Molecular Formula:C24H28N4O4
- Molecular Weight:436.5
- CAS Registry Number:1273579-40-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1273579-40-0 ROCK-II inhibitor
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.1273579-40-0 ROCK-II inhibitor
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.1273579-40-0 ROCK-II inhibitor
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:ROCK-II inhibitor
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.1273579-40-0 Acmec Chroman 1 10mg
Assay:99% Appearance:See the datasheet Package:10mg Storage:-20掳C Transportation:By Express, Air and Road Application:Analytical reagent, biochemical reagent, standard
Min. Order:1bottle
Supplier:Shanghai Acmec Biochemical Technology Co., Ltd. [
China (Mainland)] CAS No.1273579-40-0 Chroman 1
Assay:95% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:Chroman 1, a chroman-based compound, is an effective ROCK II inhibitor which could probably influence the cell motility involved in sorts of disorders.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 1168106-92-0/5-Bromo-7H-pyrrolo[2,3-d]pyrimidine-4-carbonitrile
- 1095253-39-6/ARQ 621
- 1026707-46-9/CVT-6660
- 934016-19-0/DEGARELIX ACETATE
- 1012104-68-5/1-(4-Hydroxycyclohexyl)-2-[[5-(2-trifluoromethoxyphenyl)-1H-indazol-3-yl]amino]-1H-benzimidazole-5-carboxylic acid (3-methylbutyl)amide
- 1031336-54-5/Cyclohexaneacetic acid, 4-[4-(7-aminopyrazolo[1,5-a]pyrimidin-6-yl)phenyl]-, ethyl ester, trans-
- 325970-71-6/Glycine, N-(3,5-dibroMo-4-Methylphenyl)-, 2-[(2-hydroxy-5-nitrophenyl)Methylene]hydrazide
- 101917-30-0/sodium 4-pentynoate
- 742092-03-1/ticiliMuMab treMeliMuMab
- 936850-10-1/tert-butyl 3-(1-ethoxy-2-methyl-1-oxopropan-2-yl)-3-hydroxyazetidine-1-carboxylate
- 1190094-64-4/OSI-754
- 457939-22-9/VINTAFOLIDE
- 192050-59-2/(9S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione methanesulfonate
- 1416989-59-7/2-Pyridinecarboxamide, 6-methoxy-3-[[[4-[(methylsulfinyl)methyl]-1-naphthalenyl]carbonyl]amino]-N-[(tetrahydro-2H-pyran-4-yl)methyl]-
- 1186195-60-7/MTEP
- 1192411-43-0/PENAO
- 1037779-47-7/GPR119 agonist
- 885698-98-6/6-BroMoMethyl-2-chloro-4-(Morpholin-4-yl)-thieno[3,2-d]pyriMidine
- 920113-03-7/P276
- 1273579-40-0/ROCK-II inhibitor
- 1181770-72-8/EMD638683
- 1418308-27-6/6-cyano-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-1-pentan-3-ylindole-4-carboxamide
- 1256388-51-8/Ledipasvir
- 1071638-38-4/MAC-13243
- 1359828-49-1/AC430
- 791593-56-1/BAY 74-4113
- 95716-68-0/(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-one
- 253337-60-9/(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(m-tolyl)propan-1-amine
- 211374-33-3/9H-Purine-9-propanol, 2-amino-6-chloro-β-(2,2-diethoxyethyl)-, (βR)-
- 1206801-37-7/LY 2801653 dihydrochloride